Get started
Author

Lucia Uhelska

Observed institution: Thyssenkrupp (Slovakia)
ORCID: 0009-0003-4619-0700
Observed ORCID: 0009-0003-4619-0700
OpenAlex ID: A5072573568
Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor
2022 · Veronika Nemethova, Petra Mazancova, et al. · Viruses · 3
PDF
Therapeutic oligonucleotide ASC1R shows excellent tolerability and remarkable efficacy in reducing SARS-CoV-2 mRNA levels in C57BL/6 mice
2024 · Veronika Nemethova, Petra Babiakova, et al. · Biomedicine & Pharmacotherapy · 1
ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells
2024 · Veronika Nemethova, Petra Babiakova, et al. · American Journal of Physiology-Cell Physiology
ASP210 - a Potent Oligonucleotide-Based Inhibitor for Combating Both BCR-ABL1 Dependent and Independent TKI-Resistant CML Cells
2022 · Veronika Nemethova, Petra Mazancova, et al. · Blood
Works count: 4
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type